<qa>  What is the name of the PATIENTs that are RESIDUAL MULTILENALIDOMIDE WITH OR WITHOUT IXAZOMIB CITRATE AND DEXAMETHASONE IN TREATING PATIENTS WITH RESIDUAL MULTIPLE MYELOMA AFTER DONOR STEM CELL TRANSPLANT: 